<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010076589">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Gosset, A.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Protopopescu, C.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Larmarange, Joseph</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Orne-Gliemann, J.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">McGrath, N.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Pillay, D.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Dabis, F.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Iwuji, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Boyer, S.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Retention in care trajectories of HIV-positive individuals participating in a universal test-and-treat program in rural South Africa (ANRS 12249 TasP Trial)</title>
        <secondary-title>JAIDS.Journal of Acquired Immune Deficiency Syndromes</secondary-title>
      </titles>
      <pages>375-385</pages>
      <keywords>
        <keyword>universal test and treat</keyword>
        <keyword>HIV</keyword>
        <keyword>South Africa</keyword>
        <keyword>retention in care trajectories</keyword>
        <keyword>AFRIQUE DU SUD</keyword>
      </keywords>
      <dates>
        <year>2019</year>
      </dates>
      <call-num>fdi:010076589</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>JAIDS.Journal of Acquired Immune Deficiency Syndromes</full-title>
      </periodical>
      <isbn>1525-4135</isbn>
      <accession-num>ISI:000480763600005</accession-num>
      <number>4</number>
      <electronic-resource-num>10.1097/qai.0000000000001938</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010076589</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers19-08/010076589.pdf</url>
        </pdf-urls>
      </urls>
      <volume>80</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Objective: To study retention in care (RIC) trajectories and associated factors in patients eligible for antiretroviral therapy (ART) in a universal test-and-treat setting (TasP trial, South Africa, 2012-2016). Design: A cluster-randomized trial whereby individuals identified HIV positive after home-based testing were invited to initiate ART immediately (intervention) or following national guidelines (control). Methods: Exiting care was defined as &gt;= 3 months late for a clinic appointment, transferring elsewhere, or death. Group-based trajectory modeling was performed to estimate RIC trajectories over 18 months and associated factors in 777 ART-eligible patients. Results: Four RIC trajectory groups were identified: (1) group 1 "remained" in care (reference, n = 554, 71.3%), (2) group 2 exited care then "returned" after [median (interquartile range)] 4 (3-9) months (n = 40, 5.2%), (3) group 3 "exited care rapidly" [after 4 (4-6) months, n = 98, 12.6%], and (4) group 4 "exited care later" [after 11 (9-13) months, n = 85, 10.9%]. Group 2 patients were less likely to have initiated ART within 1 month and more likely to be male, young (&lt;29 years), without a regular partner, and to have a CD4 count &gt;350 cells/mm(3). Group 3 patients were more likely to be women without social support, newly diagnosed, young, and less likely to have initiated ART within 1 month. Group 4 patients were more likely to be newly diagnosed and aged 39 years or younger. Conclusions: High CD4 counts at care initiation were not associated with a higher risk of exiting care. Prompt ART initiation and special support for young and newly diagnosed patients with HIV are needed to maximize RIC.</abstract>
      <custom6>056 ; 052</custom6>
      <custom1>UR259 / UR196</custom1>
      <custom7>Afrique du Sud</custom7>
    </record>
  </records>
</xml>
